Member Log-in

I forgot my password

Not a Member? Register

Resources

Our resource library is a searchable collection of tools and documents related to various technical areas around the Gavi transition. The library consists of research articles, policy briefs, reports, guidebooks, country data, and other resources pertinent to Gavi transition or immunization programs generally. You can filter the resources by topic, type, or country. 

Some resources are available to LNCT members only and will require logging in to view. 

Results 21 - 30 of 93

Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign

Background In April 2014, a national school-based human papillomavirus (HPV) vaccination program was rolled out in South Africa, targeting Grade 4 girls aged ≥9 years. A bivalent HPV vaccine with a 2-dose (6 months apart) schedule was used. At the request of the National Department of Health (NDoH), an external assessment of the first-dose phase … Continued

Challenges to Sustainable Immunization Systems in Gavi Transitioning Countries

Through a review of available literature on the subject, this study, conducted by WHO, documents the lack of comparative analyses on immunization system performance in countries transitioning from Gavi support. Despite increased emphasis on the importance of programmatic sustainability beyond financing through the Gavi 2016–2020 Strategy and availability of data, existing literature has predominantly documented challenges related … Continued

The Role of National Immunisation Technical Advisory Groups (NITAGs) in Strengthening National Vaccine Decision-making: A Comparative Case Study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda

Introduction Improving evidence informed decision-making in immunization is a global health priority and many low and middle-income countries have established National Immunization Technical Advisory Groups (NITAGs) as independent technical advisory bodies for this purpose. NITAG development and strengthening has received financial and technical support over the past decade, but relatively little evaluation. This study examined NITAGs in six … Continued

LNCT Webinar Resources: Vaccine Prices for Countries After Gavi Transition

The LNCT webinar, ‘Vaccine Prices for Countries After Gavi Transition,’ took place on 17 July 2018. The webinar materials were presented by Juliette Puret, Senior Program Manager, Immunization Financing and Sustainability, Gavi. Included here are the presentation materials used for the webinar. Presentation Slides: English | Français | Portugués | русский View the webinar recording here.

Projected Health Financing Transitions: Timeline and Magnitude

Projected Health Financing Transitions: Timeline and Magnitude, a new working paper that was recently released, maps out an indicative timeline of transition, along with the fiscal impact, through 2040 across five global health financing mechanisms, including Gavi, the Vaccine Alliance. Research findings from the paper show that: By 2040, Gavi will see major transformations of … Continued

LNCT Webinar Resources: Vaccine Forecasting and Budgeting Tools and Best Practices

The LNCT webinar, ‘Vaccine Forecasting and Budgeting Tools and Best Practices,’ took place on 2 July 2018. The webinar materials were presented by Souleymane Koné, Technical Officer – Vaccine Management and Logistics, World Health Organization (WHO). Included here are the presentation materials used for the webinar. Presentation Slides: English | Français  | Portugués  | русский … Continued

LNCT Webinar Resources: Where to Find Information on Vaccine Product, Price, Procurement, & Markets

The LNCT webinar, ‘Where to Find Information on Vaccine Product, Price, Procurement, & Markets,’ took place on 31 May 2018. The webinar materials were presented by Renia Coghlan, Vaccine Supply | Market Analytics, World Health Organization. Included here are the presentation materials used for the webinar.   LNCT Overview Slides: English Presentation Slides: English | … Continued

UNICEF Immunization Financing in MENA Middle-Income Countries

Most Middle East and North Africa (MENA) countries have high immunization coverage rates. But immunization coverage has dropped considerably in some (including Iraq, the Syrian Arab Republic and Yemen), due to the conflicts, instability and the prevailing geopolitical situation in the region. Approximately 1.3 million surviving infants in MENA missed their third dose of DTP … Continued

Poverty Reduction and Equity Benefits of Introducing or Scaling up Measles, Rotavirus and Pneumococcal Vaccines in Low-income and Middle-income Countries: A Modelling Study

Beyond their impact on health, vaccines can lead to large economic benefits. While most economic evaluations of vaccines have focused on the health impact of vaccines at a national scale, it is critical to understand how their impact is distributed along population subgroups. The team of researchers built a financial risk protection model to evaluate … Continued

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

A team of researchers modeled the equity impact of lives saved and medical impoverishment averted from immunization over the period 2016-30 in 41 low and middle income countries (DHS survey availability determined which countries were selected for inclusion). Of our 15 LNCT member countries, data from Armenia, Ghana, Indonesia, Nigeria, and Timor-Leste were included in … Continued

Choose a Language